Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

603 Periodical Search Results

You searched for "new" AND "targets" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 603 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

display abstract citation download email a colleague
Display:

  1. Contemporary pre-clinical development of anticancer agents – What are the optimal preclinical models? , 17 September 2009
    Giovanna Damia, Maurizio D’Incalci
    European Journal of Cancer
    November 2009 (Vol. 45, Issue 16, Pages 2768-2781)
    Abstract | Full Text | Full-Text PDF (290 KB)

  1. Genomic and proteomic technologies for individualisation and improvement of cancer treatment
    Julia Wulfkuhle, Virginia Espina, Lance Liotta, Emanuel Petricoin
    European Journal of Cancer
    November 2004 (Vol. 40, Issue 17, Pages 2623-2632)
    Abstract | Full Text | Full-Text PDF (362 KB)

  1. How to develop a successful cancer drug – molecules to medicines or targets to treatments?
    David R. Newell
    European Journal of Cancer
    March 2005 (Vol. 41, Issue 5, Pages 676-682)
    Abstract | Full Text | Full-Text PDF (132 KB)

  1. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications
    Angelika M. Burger, Arun K. Seth
    European Journal of Cancer
    October 2004 (Vol. 40, Issue 15, Pages 2217-2229)
    Abstract | Full Text | Full-Text PDF (503 KB)

  1. Individual patient data analysis to assess modifications to the RECIST criteria , 17 December 2008
    Jan Bogaerts, Robert Ford, Dan Sargent, Lawrence H. Schwartz, Larry Rubinstein, Denis Lacombe, Elizabeth Eisenhauer, Jaap Verweij, Patrick Therasse, for the RECIST Working Party
    European Journal of Cancer
    January 2009 (Vol. 45, Issue 2, Pages 248-260)
    Abstract | Full Text | Full-Text PDF (158 KB)

  1. Gene expression microarray technologies in the development of new therapeutic agents
    Paul A. Clarke, Robert te Poele, Paul Workman
    European Journal of Cancer
    November 2004 (Vol. 40, Issue 17, Pages 2560-2591)
    Abstract | Full Text | Full-Text PDF (750 KB)

  1. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer , 20 November 2008
    Marilena V. Iorio, Patrizia Casalini, Elda Tagliabue, Sylvie Ménard, Carlo M. Croce
    European Journal of Cancer
    December 2008 (Vol. 44, Issue 18, Pages 2753-2759)
    Abstract | Full Text | Full-Text PDF (247 KB)

  1. Discovering novel chemotherapeutic drugs for the third millennium
    M.D. Garrett, P. Workman
    European Journal of Cancer
    December 1999 (Vol. 35, Issue 14, Pages 2010-2030)
    Abstract | Full Text | Full-Text PDF (465 KB)

  1. Update on NCI in vitro drug screen utilities
    S.L Holbeck
    European Journal of Cancer
    April 2004 (Vol. 40, Issue 6, Pages 785-793)
    Abstract | Full Text | Full-Text PDF (298 KB)

  1. The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: An overview
    James A. Crowell
    European Journal of Cancer
    September 2005 (Vol. 41, Issue 13, Pages 1889-1910)
    Abstract | Full Text | Full-Text PDF (304 KB)

  1. Multiple targeted tyrosine kinase inhibition in the clinic: All for one or one for all?
    M.J.A. de Jonge, J. Verweij
    European Journal of Cancer
    July 2006 (Vol. 42, Issue 10, Pages 1351-1356)
    Abstract | Full Text | Full-Text PDF (127 KB)

  1. Achievements and future of chemotherapy
    J Verweij, M.J.A de Jonge
    European Journal of Cancer
    August 2000 (Vol. 36, Issue 12, Pages 1479-1487)
    Abstract | Full Text | Full-Text PDF (127 KB)

  1. Cancer chemoprevention: progress and promise
    G.J. Kelloff, C.C. Sigman, P. Greenwald
    European Journal of Cancer
    December 1999 (Vol. 35, Issue 13, Pages 1755-1762)
    Abstract | Full Text | Full-Text PDF (117 KB)

  1. 17th meeting of the European Association for Cancer Research in Granada, Spain, 8–11 June 2002
    S. Eccles
    European Journal of Cancer
    October 2002 (Vol. 38, Issue 15, Pages 1975-1983)
    Full Text | Full-Text PDF (130 KB)

  1. Cancer chemoprevention: progress and promise
    G.J. Kelloff, C.C. Sigman, P. Greenwald
    European Journal of Cancer
    December 1999 (Vol. 35, Issue 14, Pages 2031-2038)
    Abstract | Full Text | Full-Text PDF (120 KB)

  1. Current research and treatment for epithelial ovarian cancer A Position Paper from the Helene Harris Memorial Trust
    F. Balkwill, R.C. Bast, J. Berek, G. Chenevix-Trench, M. Gore, T. Hamilton, I. Jacobs, G. Mills, R. Souhami, N. Urban, S. Ursulic, J. Smyth
    European Journal of Cancer
    September 2003 (Vol. 39, Issue 13, Pages 1818-1827)
    Abstract | Full Text | Full-Text PDF (184 KB)

  1. Cancer therapeutics: Targeting the dark side of Myc
    Romina Ponzielli, Sigal Katz, Dalia Barsyte-Lovejoy, Linda Z. Penn
    European Journal of Cancer
    November 2005 (Vol. 41, Issue 16, Pages 2485-2501)
    Abstract | Full Text | Full-Text PDF (391 KB)

  1. EACR-19: The best of European cancer research
    V. Jendrossek
    European Journal of Cancer
    December 2006 (Vol. 42, Issue 18, Pages 3084-3094)
    Abstract | Full Text | Full-Text PDF (191 KB)

  1. The role of microRNAs in cancer: No small matter
    Erik A.C. Wiemer
    European Journal of Cancer
    July 2007 (Vol. 43, Issue 10, Pages 1529-1544)
    Abstract | Full Text | Full-Text PDF (517 KB)

  1. Ras and Rho GTPases: targets of FTase and GGTase I inhibitors for cancer treatment?
    European Journal of Cancer
    November 2002 (Vol. 38Supplement 7, Page S100)
    Full-Text PDF (157 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 603 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.